Ceasing to be a substantial holder
Released
Released
Announcement PDF
Form 605
Corporations Act 2001
Section 671B
Notice of ceasing to be a substantial holder
To Company Name/Scheme
Percheron Therapeutics Limited
ACN/ARSN
095 060 745
1. Details of substantial holder (1)
Gregory Norman Peters and each of the persons named in Annexure A.
Name
ACN/ARSN (if applicable)
The holder ceased to be a substantial holder on
4 March 2025
The previous notice was given to the company on
6 January 2025
The previous notice was dated
6 January 2025
2. Changes in relevant interests
Particulars of each change in, or change in the nature of, a relevant interest (2) of the substantial holder or an associate (3) in voting securities
of the company or scheme, since the substantial holder was last required to give a substantial holding notice to the company or scheme are as
follows:
Date of
change
Person whose
relevant interest
changed
4 March
2025
Nature of Change (4)
Parties in Annexure A have
ceased to be associated by virtue
of the resolutions proposed by
them under section 249D of the
Corporations Act having been
considered at a general meeting
of shareholders on 4 March 2025.
No change
Consideration
given in relation
to change (5)
Class (6) and
number of
securities affected
Person’s
votes
affected
n/a
n/a
n/a
3. Changes in association
The persons who have become associates (3) of, ceased to be associates of, or have changed the nature of their association (7) with, the
substantial holder in relation to voting interests in the company or scheme are as follows:
Name and ACN/ARSN (if applicable)
Nature of association
n/a
n/a
4. Addresses
The addresses of persons named in this form are as follows:
Name
Address
For all parties
c/- Level 6, 400 Collins Street, Melbourne, Victoria, 3000
Signature
print name
sign here
Gregory Norman Peters
capacity
date
4 March 2025
DIRECTIONS
(1)
If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the
manager and trustee of an equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons
are essentially similar, they may be referred to throughout the form as a specifically named group if the membership of each group, with the
names and addresses of members is clearly set out in paragraph 4 of the form.
(2)
See the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001.
(3)
See the definition of "associate" in section 9 of the Corporations Act 2001.
(4)
Include details of:
(a)
any relevant agreement or other circumstances because of which the change in relevant interest occurred. If subsection 671B(4)
applies, a copy of any document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate
details of any contract, scheme or arrangement, must accompany this form, together with a written statement certifying this contract,
scheme or arrangement; and
(b)
any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal
of the securities to which the relevant interest relates (indicating clearly the particular securities to which the qualification applies).
See the definition of "relevant agreement" in section 9 of the Corporations Act 2001.
(5)
Details of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest was acquired
has, or may, become entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening
or not of a contingency. Details must be included of any benefit paid on behalf of the substantial holder or its associate in relation to the
acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired.
(6)
The voting shares of a company constitute one class unless divided into separate classes.
(7)
Give details, if appropriate, of the present association and any change in that association since the last substantial holding notice.
Annexure A
Holder of relevant interest
Gregory Norman Peters
Nature of relevant interest (7)
Class and number of
securities
Each of the parties set out in Annexure A
had a relevant interest in each others
shares as a result of being signatories to a
notice issued under section 249D of the
Corporations Act 249D Notice) and
therefore previously deemed to be acting in
concert in respect of the resolutions
proposed in that notice. Expect where
identified as “associates” being, in which
case the holder is an associate of a
signatory to the 249D Notice.
Ordinary – 12,675,000
Dale Anthony Reed
As above.
Ordinary – 15,050,000
Robert William Moses
As above,
Ordinary – 8,000,000
Statemoor Pty Ltd <Peters SF A/C> As above.
Ordinary – 4,893,269
Xcelerate Nominees Pty Ltd
<Xcelerate Super Fund A/C>
As above,
Ordinary – 3,930,710
David Kenley
As above.
Ordinary – 3,800,000
XEC Partners Pty Ltd <XEC
Partners A/C>
As above,
Ordinary – 3,204,358
Xcelerate Trading Pty Ltd
<Xcelerate Trading A/C>
As above,
Ordinary -2,238,703
Statemoor Pty Ltd <Peters Family As above,
A/C>
Ordinary – 1,044,231
David Kenley <Kenley Super Plan Associate of David Kenley.
A/C>
Ordinary – 250,000
David Kenley <One Plus 1 A/C>
Associate of David Kenley.
Ordinary – 88,810
Noelle Kenley
Associate of David Kenley.
Ordinary – 170,000
Share your feedback
Discover